‘Humanosphere’ blog examines roles of former President Carter, researcher Foege in fighting NTDs
This post in KPLU 88.5's "Humanosphere" blog examines how former President Jimmy Carter gave the fight against neglected tropical diseases (NTDs) "a good first shove nearly 30 years ago," writing, "Neglected diseases like river blindness, Guinea worm, parasitic (lymphatic) elephantiasis and schistosomiasis have been in Carter's cross hairs since the ...
Aspirin and warfarin similar in preventing deaths and strokes in heart failure patients
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
G-CSF’s AX200 does not improve stroke-related disability
A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
Soy isoflavone supplements do not reduce breast cancer cell proliferation
Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Increased exposure to sunlight may prevent allergies and eczema
Increased exposure to sunlight may reduce the risk of both food allergies and eczema in children, according to a new scientific study published this week.
New experimental device effectively removes blood clots in stroke patients
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.
Positive updated results from Aeterna Zentaris’ AEZS-108 Phase 1 trial on CRPC
Aeterna Zentaris Inc. today reported positive updated results for the Phase 1 portion of its ongoing Phase 1/2 study in castration- and taxane-resistant prostate cancer (CRPC) with AEZS-108 (zoptarelin doxorubicin), the Company's targeted cytotoxic luteinizing hormone-releasing hormone (LHRH) analog.
Superb website…
[...]always a big fan of linking to bloggers that I love but don’t get a lot of link love from[...]……
Check this out…
[...] that is the end of this article. Here you’ll find some sites that we think you’ll appreciate, just click the links over[...]……
Superb website…
[...]always a big fan of linking to bloggers that I love but don’t get a lot of link love from[...]……
Recommeneded websites…
[...]Here are some of the sites we recommend for our visitors[...]……
Great website…
[...]we like to honor many other internet sites on the web, even if they aren’t linked to us, by linking to them. Under are some webpages worth checking out[...]……
You should check this out…
[...] Wonderful story, reckoned we could combine a few unrelated data, nevertheless really worth taking a look, whoa did one learn about Mid East has got more problerms as well [...]……
Awesome website…
[...]the time to read or visit the content or sites we have linked to below the[...]……
[...]the time to read or visit the content or sites we have linked to below the[...]……
[...]here are some links to sites that we link to because we think they are worth visiting[...]……
Related……
[...]just beneath, are numerous totally not related sites to ours, however, they are surely worth going over[...]……
Websites you should visit…
[...]below you’ll find the link to some sites that we think you should visit[...]……
asklover…
[...]Here is a superb Blog You might Come across Interesting that we Encourage You[...]…
Superb website…
[...]always a big fan of linking to bloggers that I love but don’t get a lot of link love from[...]……
Sites we Like……
[...] Every once in a while we choose blogs that we read. Listed below are the latest sites that we choose [...]……
Visitor recommendations…
[...]one of our visitors recently recommended the following website[...]……
[...]always a big fan of linking to bloggers that I love but don’t get a lot of link love from[...]……
[...]just beneath, are numerous totally not related sites to ours, however, they are surely worth going over[...]……
Recommended websites…
[...]Here are some of the sites we recommend for our visitors[...]……